Clearside Biomedical, Inc. — Director's Dealing 2024

May 15, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Clearside Biomedical, Inc. (CLSD)
CIK: 0001539029
Period of Report: 2024-05-15

Reporting Person: YERXA BENJAMIN R (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-15	Common Stock	P	7813	$1.31	Acquired	17957	Direct